← brief for 2026-08-17 · Slowing decline

Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes.

Article C Peer reviewed Observational

Key takeaways

This study reviewed health records of many adults with type 2 diabetes in Australia. People who were admitted to the hospital were more likely to stop taking their SGLT2 inhibitor, a drug that protects the kidneys and heart. This shows a link, not proof that the hospital stay caused people to quit. Stopping these drugs takes away their protection.

Who did this work

Milder TY · Shepherd L · Raket HK · Greenfield JR · Day RO · Lin J · de Oliveira Costa J · Stocker S · Pollock CA · Neuen B · Jun M · Ludington J

Source

Article · PubMed, the drug frontier · 2026 Aug 17
https://pubmed.ncbi.nlm.nih.gov/42608294/